IDEAS home Printed from https://ideas.repec.org/a/pkp/joucel/v2y2017i1p6-14id2404.html
   My bibliography  Save this article

Gender as Determinant of the Effect of Yeast Selenium on CD4 T Cells Count Among HIV 1 Positive Children

Author

Listed:
  • Samwel Boaz Otieno

Abstract

Background Sex steroid estrogens (E2) have been observed to have synergistic effect on activity of GSH-px on pre-menopausal females taking selenium. GSH-px activity is correlated to CD4 T cell count in HIV positive patients. However no study has been done to determine gender differentiated effect of yeast selenium intake on CD4 T cell count of pre-puberty male and female children. Methods In the study 25 girls and 25 boys HIV-1 positive on WHO stage three and below were given 50μg yeast selenium and blood samples taken at zero, three and six months intervals in EDTA vacuutainers. The blood samples were analyzed for CD4 T cell count by ELISA. Results: No significant CD4 T cell count change in the test group = -2.943,p< 0.05 compared to the matched controls t = -1.258 p> 0.05. CD4 T cell count increased among all age groups on test 3-5years (+ 267.1),5-8 years( +200.3) 9-15 years (+71.2) cells/mm3 and while in matched controls there was a decrease in all age groups 3-5 years(-71),5-8 years (-125) and 9-13years(-10.1)cells/mm3 . No significant difference was observed in CD4 T cell count between boys and Girls {F (df 5, 81) = 1.379 p=0.241} between girls {F ( df 2,32) = 1.531, p= 0.232} and between boys { F ( df 2, 49) = 1.040, p= 0.361} on selenium and between boys and girls {F (df 5, 86) = 1.168, p= 0.332} on control at six months. Conclusion It can be concluded that there was significant increase in CD4 T cell count among the children on selenium, but no significant difference in the effect of selenium on CD4 T cell count between pre-menopausal females and male.

Suggested Citation

  • Samwel Boaz Otieno, 2017. "Gender as Determinant of the Effect of Yeast Selenium on CD4 T Cells Count Among HIV 1 Positive Children," Journal of Cells, Conscientia Beam, vol. 2(1), pages 6-14.
  • Handle: RePEc:pkp:joucel:v:2:y:2017:i:1:p:6-14:id:2404
    as

    Download full text from publisher

    File URL: https://archive.conscientiabeam.com/index.php/97/article/view/2404/3638
    Download Restriction: no

    File URL: https://archive.conscientiabeam.com/index.php/97/article/view/2404/5841
    Download Restriction: no
    ---><---

    More about this item

    Keywords

    Selenium; Gender; Estrogens; HIV; Sex; Age;
    All these keywords.

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:pkp:joucel:v:2:y:2017:i:1:p:6-14:id:2404. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Dim Michael (email available below). General contact details of provider: https://archive.conscientiabeam.com/index.php/97/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.